0001792612-19-000002.txt : 20191031
0001792612-19-000002.hdr.sgml : 20191031
20191031132055
ACCESSION NUMBER: 0001792612-19-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20191031
DATE AS OF CHANGE: 20191031
EFFECTIVENESS DATE: 20191031
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avenzoar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001792612
IRS NUMBER: 475352251
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-352278
FILM NUMBER: 191182957
BUSINESS ADDRESS:
STREET 1: 662 ENCINITAS BLVD., SUITE 248
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: (310) 502-0770
MAIL ADDRESS:
STREET 1: 662 ENCINITAS BLVD., SUITE 248
CITY: ENCINITAS
STATE: CA
ZIP: 92024
D
1
primary_doc.xml
X0708
D
LIVE
0001792612
Avenzoar Pharmaceuticals, Inc.
662 ENCINITAS BLVD., SUITE 248
ENCINITAS
CA
CALIFORNIA
92024
858-356-9563
CALIFORNIA
None
None
Corporation
true
2015
Terrance
Bruggeman
c/o Avenzoar Pharmaceuticals, Inc.
662 Encinitas Blvd., Suite 248
Encinitas
CA
CALIFORNIA
92024
Executive Officer
Director
William
Reavey
c/o Avenzoar Pharmaceuticals, Inc.
662 Encinitas Blvd., Suite 248
Encinitas
CA
CALIFORNIA
92024
Executive Officer
David
Kramer
c/o Avenzoar Pharmaceuticals, Inc.
662 Encinitas Blvd., Suite 248
Encinitas
CA
CALIFORNIA
92024
Executive Officer
Mouad
Edderkaoui
c/o Avenzoar Pharmaceuticals, Inc.
662 Encinitas Blvd., Suite 248
Encinitas
CA
CALIFORNIA
92024
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2019-10-17
false
true
true
false
0
918172
525144
393028
false
4
0
0
0
false
Avenzoar Pharmaceuticals, Inc.
/s/ Terrance Bruggeman
Terrance Bruggeman
Chief Executive Officer
2019-10-31